{
  "abstract": "The UK Government‘s 10-Year Health Plan for England identifies a problem: patients do not consistently receive rapid and equitable treatment with cost-effective medicines.1 However, the proposed Single National Formulary (SNF) risks repeating past mistakes by attempting to solve the wrong problems and is already drawing concerns from local National Health Service (NHS) teams and industry alike.2",
  "authors": [
    {
      "affiliations": [
        "Pharmacy Department, University College London Hospitals NHS Foundation Trust, London, UK",
        "North Central London Joint Formulary Committee, London, UK"
      ],
      "name": "Sonali Sanghvi"
    },
    {
      "affiliations": [
        "Pharmacy Department, University College London Hospitals NHS Foundation Trust, London, UK"
      ],
      "name": "Andrew Barron"
    },
    {
      "affiliations": [
        "Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK"
      ],
      "name": "John Minshull"
    }
  ],
  "title": "Single National Formulary: solution or distraction?",
  "uid": "fddb3ab9-464e-5286-b2a4-c88d7c016b8a"
}